Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes

NCT01850615 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01850615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01850615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
September 23, 2013
Completion date
November 17, 2014
Enrollment
323 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2